Xarelto Lawsuit Plaintiffs Claim Manufacturers Misleadingly Marketed Blood Thinning Drug

February 25, 2016 – – BloodThinnerHelp.com reports on a Xarelto lawsuit which has been filed against the manufacturers of the blood thinner: Janssen Pharmaceuticals (a division of Johnson & Johnson corporation) and Bayer Healthcare. The plaintiff filing this lawsuit claims that each of the manufacturers have fraudulently misrepresented the benefits and potential dangers of their new-generation anticoagulant through misleading marketing tactics. The complaint is a larger one, involving a total of 32 counts against the corporations, and was filed on October 13, 2015 in the St. Clair County Circuit Court under case number 15-L-581.

The lawsuit plaintiff also claims that Xarelto manufacturers failed to properly warn doctors of the possibly serious side effects that could be caused by their drug, specifically surrounding sudden bleeding episodes, which, at the time of the suit, were difficult to treat as the drug offered no antidote to patients using it for years. In court documentation, the plaintiff indicates that Xarelto was fraudulently marketed, with commercials that focused primarily on the drug’s benefits and failed to adequately discuss the dangers. In addition, many have noted the use of famous celebrities in Xarelto commercials, which commonly spotlight successful athletes of the past and present. The plaintiff is requesting damages exceeding $50,000, and financial coverage for any legal fees he might incur.

Xarelto lawsuits have been filed in large numbers from across the United States. Today, in federal court, there are over 2,800 Xarelto lawsuits which have been consolidated by the U.S. JPML to form MDL Number 2592. In Philadelphia, Pennsylvania as well, another group of over 550 cases has been consolidated to form a mass tort group by the Court of Common Pleas. All of the Xarelto lawsuits filed in each grouping share strikingly common allegations against the same defendants, which claim that Xarelto use can put patients at increased risk for serious and sudden bleeding episodes. In addition, several studies have now linked the drug to increased risk of different types of bleeding episodes.

Cases involved in the MDL are being overseen by the Honorable Judge Eldon Fallon and are expected to continue to grow in number as they await further trial preparations. Bellwether trials for these cases are currently scheduled for early 2017. At this time, Attorney Joseph Osborne is working to help ensure that anyone who believes they were negatively affected by Xarelto will have the ability to explore their legal rights in full. He is offering free legal consultations to affected individuals. These patients may be entitled to significant compensation.

To request additional information on Xarelto lawsuits, or to ask questions, please contact Joseph Osborne, Esq. by calling (866) 425-8902.

###

Contact BloodThinnerHelp.com:

Joseph Osborne
866-425-8902
Mizner Park
433 Plaza Real Blvd., Ste. 271
Boca Raton, FL 33432

ReleaseID: 60008359